Merck Darmstadt Germany

Germany's Merck in advanced talks to acquire US biotech firm SpringWorks

(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") By Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) -Merck KGaA,

The Wall Street Journal on MSN · 1d

Germany’s Merck in Talks to Buy SpringWorks Therapeutics

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Hartford Business · 2d

CT drugmaker in ‘advanced talks’ to be acquired by Germany’s Merck

Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and cancer, is in “advanced talks” to be acquired by Germany’s Merck, according to Reuters.

Hosted on MSN · 2d

Exclusive-Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics, according to people familiar with the matter.

Business Wire21d

Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver Leave Benefit as an addition ...

Nasdaq25d

Lobbying Update: $80,000 of MERCK KGAA DARMSTADT GERMANY lobbying was just disclosed

$80,000 of MERCK KGAA DARMSTADT GERMANY lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to chemical ...

Cosmetics Business2d

High performance meets metallic magic with Ronaflux® cosmetic pigments

EMD Electronics, the North American pigments division of Merck KGaA, Darmstadt, Germany, has launched Ronaflux® cosmetic ...

Business Wire20d

MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future

BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and ...

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results